Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 3
2022 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Explaining dissolution properties of rivaroxaban cocrystals.
Hriňová E, Skořepová E, Čerňa I, Královičová J, Kozlík P, Křížek T, Roušarová J, Ryšánek P, Šíma M, Slanař O, Šoóš M. Hriňová E, et al. Among authors: rousarova j. Int J Pharm. 2022 Jun 25;622:121854. doi: 10.1016/j.ijpharm.2022.121854. Epub 2022 May 25. Int J Pharm. 2022. PMID: 35623488
Application of Oil-in-Water Cannabidiol Emulsion for the Treatment of Rheumatoid Arthritis.
Jelínek P, Roušarová J, Ryšánek P, Ježková M, Havlůjová T, Pozniak J, Kozlík P, Křížek T, Kučera T, Šíma M, Slanař O, Šoóš M. Jelínek P, et al. Among authors: rousarova j. Cannabis Cannabinoid Res. 2024 Feb;9(1):147-159. doi: 10.1089/can.2022.0176. Epub 2022 Nov 4. Cannabis Cannabinoid Res. 2024. PMID: 36342775
Validity of cycloheximide chylomicron flow blocking method for the evaluation of lymphatic transport of drugs.
Ryšánek P, Grus T, Lukáč P, Kozlík P, Křížek T, Pozniak J, Roušarová J, Královičová J, Kutinová Canová N, Boleslavská T, Bosák J, Štěpánek F, Šíma M, Slanař O. Ryšánek P, et al. Among authors: rousarova j. Br J Pharmacol. 2021 Dec;178(23):4663-4674. doi: 10.1111/bph.15644. Epub 2021 Sep 10. Br J Pharmacol. 2021. PMID: 34365639 Free article.
Pharmacokinetic Variability in Pre-Clinical Studies: Sample Study with Abiraterone in Rats and Implications for Short-Term Comparative Pharmacokinetic Study Designs.
Královičová J, Bartůněk A, Hofmann J, Křížek T, Kozlík P, Roušarová J, Ryšánek P, Šíma M, Slanař O. Královičová J, et al. Among authors: rousarova j. Pharmaceutics. 2022 Mar 15;14(3):643. doi: 10.3390/pharmaceutics14030643. Pharmaceutics. 2022. PMID: 35336017 Free PMC article.
Bioavailability Enhancement and Food Effect Elimination of Abiraterone Acetate by Encapsulation in Surfactant-Enriched Oil Marbles.
Boleslavská T, Rychecký O, Krov M, Žvátora P, Dammer O, Beránek J, Kozlík P, Křížek T, Hořínková J, Ryšánek P, Roušarová J, Canová NK, Šíma M, Slanař O, Štěpánek F. Boleslavská T, et al. Among authors: rousarova j. AAPS J. 2020 Sep 25;22(6):122. doi: 10.1208/s12248-020-00505-5. AAPS J. 2020. PMID: 32978690
Factors Affecting the Metabolic Conversion of Ciprofloxacin and Exposure to Its Main Active Metabolites in Critically Ill Patients: Population Pharmacokinetic Analysis of Desethylene Ciprofloxacin.
Šíma M, Bobek D, Cihlářová P, Ryšánek P, Roušarová J, Beroušek J, Kuchař M, Vymazal T, Slanař O. Šíma M, et al. Among authors: rousarova j. Pharmaceutics. 2022 Aug 4;14(8):1627. doi: 10.3390/pharmaceutics14081627. Pharmaceutics. 2022. PMID: 36015253 Free PMC article.